SPA
OM icon

Sherbrooke Park Advisers’s Outset Medical OM Stock Holding History

Sherbrooke Park Advisers’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,068
Closed -$10.8K – 1052
2024
Q3 		$10.8K Buy
+1,068
New +$31.8K ﹤0.01% 874
2024
Q1 		– Sell
-934
Closed -$75.8K – 954
2023
Q4 		$75.8K Buy
+934
New +$76K 0.04% 420

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sherbrooke Park Advisers's OM Position: Q4 2024 in Review

Sherbrooke Park Advisers sold out of Outset Medical (OM) in Q4 2024, closing a stake of 1,068 shares — an estimated $10.8K sold.

Sherbrooke Park Advisers first reported a position in OM in Q4 2023 and held it in 2 quarters. The position peaked at $75.8K in Q4 2023. 73 funds tracked by Wall St. Rank hold OM as of Q4 2024.

  • Sherbrooke Park Advisers reported no remaining Outset Medical position as of Q4 2024 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 1,068 Outset Medical shares in Q4 2024, an estimated $10.8K.
  • Sherbrooke Park Advisers first reported a position in Outset Medical in Q4 2023 and held it in 2 quarters.
  • Sherbrooke Park Advisers's Outset Medical position peaked at $75.8K in Q4 2023.
  • 73 funds tracked by Wall St. Rank held Outset Medical as of Q4 2024.

Based on Sherbrooke Park Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.